CN1751036A - 取代的3－(苯甲酰脲基)－噻吩衍生物,其制备方法以及应用 - Google Patents

取代的3－(苯甲酰脲基)－噻吩衍生物,其制备方法以及应用 Download PDF

Info

Publication number
CN1751036A
CN1751036A CNA2004800044004A CN200480004400A CN1751036A CN 1751036 A CN1751036 A CN 1751036A CN A2004800044004 A CNA2004800044004 A CN A2004800044004A CN 200480004400 A CN200480004400 A CN 200480004400A CN 1751036 A CN1751036 A CN 1751036A
Authority
CN
China
Prior art keywords
alkyl
formula
agonist
phenyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800044004A
Other languages
English (en)
Chinese (zh)
Inventor
K·舍纳芬格
E·德福萨
E·冯勒德恩
D·卡德莱特
A·赫林
H－J·布格尔
T·克拉邦德
K-U·文特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Publication of CN1751036A publication Critical patent/CN1751036A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/42—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
    • C07D333/44—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms attached in position 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA2004800044004A 2003-02-17 2004-02-04 取代的3－(苯甲酰脲基)－噻吩衍生物,其制备方法以及应用 Pending CN1751036A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10306502.4 2003-02-17
DE10306502A DE10306502B4 (de) 2003-02-17 2003-02-17 Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CN1751036A true CN1751036A (zh) 2006-03-22

Family

ID=32841675

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800044004A Pending CN1751036A (zh) 2003-02-17 2004-02-04 取代的3－(苯甲酰脲基)－噻吩衍生物,其制备方法以及应用

Country Status (21)

Country Link
EP (1) EP1597247B1 (enExample)
JP (1) JP4589301B2 (enExample)
KR (1) KR20050105470A (enExample)
CN (1) CN1751036A (enExample)
AR (1) AR043179A1 (enExample)
AT (1) ATE402160T1 (enExample)
AU (1) AU2004212054A1 (enExample)
BR (1) BRPI0407552A (enExample)
CA (1) CA2516269A1 (enExample)
CO (1) CO5690549A2 (enExample)
DE (2) DE10306502B4 (enExample)
HR (1) HRP20050715A2 (enExample)
MA (1) MA27657A1 (enExample)
MX (1) MXPA05008331A (enExample)
NO (1) NO20054168L (enExample)
PE (1) PE20050221A1 (enExample)
PL (1) PL376753A1 (enExample)
RU (1) RU2005129109A (enExample)
TW (1) TW200505892A (enExample)
WO (1) WO2004072060A1 (enExample)
ZA (1) ZA200505487B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006053274A2 (en) 2004-11-15 2006-05-18 Bristol-Myers Squibb Company 2-amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
WO2006055463A2 (en) 2004-11-15 2006-05-26 Bristol-Myers Squibb Company 2-amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
WO2006055462A1 (en) 2004-11-15 2006-05-26 Bristol-Myers Squibb Company 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
US7223786B2 (en) 2004-11-15 2007-05-29 Bristol-Myers Squibb Company 2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors
JP2008536932A (ja) * 2005-04-18 2008-09-11 サイード・アール・カーン チューブリン重合阻害剤：ボンゾイルフェニル尿素（ｂｐｕ）硫黄類似体の設計及び合成
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
CA3144848C (en) * 2019-06-28 2023-11-21 Pfizer Inc. 5-(thiophen-2-yl)-1h-tetrazole derivatives as bckdk inhibitors useful for treating various diseases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034004A1 (de) * 1980-09-10 1982-04-22 Hoechst Ag, 6000 Frankfurt Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
HUT48880A (en) * 1987-07-20 1989-07-28 Sandoz Ag Insecticides and acaricides comprising new n-benzoyl-n'-thienyl urea derivative as active ingredient and process for producing the active ingredients
EP1294682B1 (de) * 2000-06-09 2004-04-28 Aventis Pharma Deutschland GmbH Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE10116768A1 (de) * 2001-04-04 2002-10-10 Aventis Pharma Gmbh Acylphenylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PE20021091A1 (es) * 2001-05-25 2003-02-04 Aventis Pharma Gmbh Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion
DE10215908B4 (de) * 2002-04-11 2005-08-18 Aventis Pharma Deutschland Gmbh Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel
DE10215907A1 (de) * 2002-04-11 2003-11-06 Aventis Pharma Gmbh Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
DE10225635C1 (de) * 2002-06-07 2003-12-24 Aventis Pharma Gmbh N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung
MXPA05000055A (es) * 2002-07-11 2005-04-08 Aventis Pharma Gmbh Acilureas sustituidas con urea y uretano, metodos para su produccion y su uso.
ATE452879T1 (de) * 2002-07-12 2010-01-15 Sanofi Aventis Deutschland Heterozyklisch substituierte benzoylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE10246434B4 (de) * 2002-10-04 2005-08-04 Aventis Pharma Deutschland Gmbh Carboxyalkoxy-substituierte Acyl-carboxyphenyl-harnstoffderivate und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
DE502004007668D1 (de) 2008-09-04
PL376753A1 (pl) 2006-01-09
AR043179A1 (es) 2005-07-20
DE10306502B4 (de) 2005-03-17
JP4589301B2 (ja) 2010-12-01
RU2005129109A (ru) 2006-01-27
CO5690549A2 (es) 2006-10-31
ATE402160T1 (de) 2008-08-15
AU2004212054A1 (en) 2004-08-26
NO20054168D0 (no) 2005-09-07
ZA200505487B (en) 2006-08-30
JP2006517933A (ja) 2006-08-03
PE20050221A1 (es) 2005-04-04
KR20050105470A (ko) 2005-11-04
MA27657A1 (fr) 2005-12-01
WO2004072060A1 (de) 2004-08-26
CA2516269A1 (en) 2004-08-26
EP1597247B1 (de) 2008-07-23
HRP20050715A2 (en) 2006-09-30
DE10306502A1 (de) 2004-09-09
EP1597247A1 (de) 2005-11-23
MXPA05008331A (es) 2005-09-30
NO20054168L (no) 2005-11-11
TW200505892A (en) 2005-02-16
BRPI0407552A (pt) 2006-02-14

Similar Documents

Publication Publication Date Title
CN1286805C (zh) 酰基－4－羧基苯基脲衍生物、其制备方法及用途
US7453009B2 (en) Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use
JP2008526696A (ja) スルホニルピロリジン類、それらを製造する方法及び薬物としてのそれらの使用
RU2377242C2 (ru) Замещенные производные оксазол-бензоизотиазолдиоксида, способ их получения и их применения
JP4658607B2 (ja) ホルモン感受性リパーゼの新規な二環式阻害剤
CN1829715A (zh) 取代的噻唑－苯并异噻唑二氧化物衍生物、其制备方法和其用途
JP2008533067A (ja) アミド置換８−ｎ−ベンゾイミダゾール、その製造方法、及びその医薬としての使用
JP2008533065A (ja) アミノカルボニル置換８−ｎ−ベンゾイミダゾール、その製造方法及びその医薬としての使用
JP4398859B2 (ja) Ｎ−ベンゾイルウレイド桂皮酸誘導体、それらの製造法、およびそれらの使用
JP4374428B2 (ja) 尿素置換されたおよびウレタン置換されたアシル尿素、それらの製造方法および医薬としてのそれらの使用方法
CN1910181A (zh) 杂环基取代的7－氨基－4－喹诺酮－3－甲酸衍生物、其生产方法及其作为药物的用途
JP4589301B2 (ja) 置換された３−（ベンゾイルウレイド）−チオフェン誘導体その製造方法および使用
CN1910182A (zh) 环烷基取代的7－氨基－4－喹诺酮－3－甲酸衍生物、其制备方法及其作为药物的用途
CN1759109A (zh) 取代的苯甲酰基脲基吡啶基－哌啶－和－吡咯烷甲酸衍生物,它们的制备方法和用途
CN1798730A (zh) 碳酰氨基取代的酰基苯基脲衍生物、其制备方法和用途
US7196114B2 (en) Substituted 3-(benzoylureido) thiophene derivatives, processes for preparing them and their use
CN1914206A (zh) 7－苯基氨基－4－喹诺酮－3－甲酸衍生物、其生产方法及其作为药物的用途
HK1086258A (en) Substituted 3-(benzoylureido)-thiophene derivatives, method for the production and use thereof
JP4355290B2 (ja) カルボキシアルコキシ置換アシル−カルボキシフェニル尿素誘導体、その製造方法、および医薬品としてのその使用
JP2008533066A (ja) アミノ置換８−ｎ−ベンゾイミダゾールの使用
CA2534473A1 (en) Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same
HK1076447A (en) N-benzoylureidocinnamate derivatives, method for production and use thereof
HK1116475A (en) Sulfonyl pyrrolidines, method for producing the same and their use as drugs
HK1090024A (en) Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof
HK1103396A (en) Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1086258

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1086258

Country of ref document: HK